NPPES file of Aug 9, 2026

Daro Mendoza Largoza, MD

Research Study Specialist · New York, NY

Daro Mendoza Largoza, MD is a research study specialist with a practice address in New York, New York, and NPI 1063746014, issued on Sep 23, 2009. Check the license (New York 226955, as entered in NPPES) with the New York board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1063746014
Name
Daro Mendoza Largoza
Credential
MD
Primary taxonomy
Research Study Specialist 1744R1102X
License number
226955 NY
Self-reported in NPPES; status is on the state search
Practice location
50 West 34TH. St., New York, NY 10001
Phone
(347) 526-1810
Enumerated
Sep 23, 2009
Record last updated
Sep 23, 2009 (not updated in 17 years: call before relying on the address or phone)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Daro Mendoza Largoza in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich New York board licenses this profession
    Search for license 226955
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the New York license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

33% more Medicare Part D claims than the average research study specialist in 2024

412 Medicare Part D claims for 36 beneficiaries, against an average of 309 among the 12 providers of this specialty who prescribed in Part D. Brand-name drugs were 11% of claims.

  1. Daro Largoza412
  2. Specialty average309

Most prescribed

  1. Atorvastatin Calcium35 claims
  2. Pantoprazole Sodium31 claims
  3. Metformin Hcl19 claims
  4. Lisinopril18 claims
  5. Tamsulosin Hcl18 claims
  6. Levothyroxine Sodium17 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $108.80

1 payment: food and beverage; the largest payer was Neurocrine Biosciences, Inc. The 14 providers of this specialty with any payment received $4,217.62 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Daro Largoza$108.80
  2. Specialty average$4,217.62

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Daro Mendoza Largoza among 25 research study specialist records in New York

Daro Mendoza Largoza, MD is one of 25 research study specialist records with a practice address in New York. 4% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 8% of them.

  • NPI issued2009 · 8% of these records are older, 88% newer
  • In a Medicare fileYes · 4% of these records are
  • In the CMS Doctors and Clinicians fileNo · 0% of these records are
  • Record last updated2009 · 72% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1744R1102X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Research Study Specialist providers in New York

There are 25 research study specialist records in New York.

The 8 research study specialist records with the nearest ZIP codes

  1. Julian Freed-Brown, PHDNew York, NY 100131215580089
  2. Alen Agaronov, SCD, RDNNew York, NY 100161487389367
  3. Antonio ConvitNew York, NY 100161164878690
  4. Vani Halahalli Srinivasa, MSNew York, NY 100161730490749
  5. Akihiro Takamiya, MD, PHDNew York, NY 100191679420962
  6. Lester Salans, M.D.New York, NY 100211295756468
  7. Cheryl-Ann Eccles, RNNew York, NY 100271932452570
  8. Ipek Ensari, PHDNew York, NY 100291164303798

Common questions

What is Daro Mendoza Largoza, MD's NPI number?

Daro Mendoza Largoza, MD's National Provider Identifier (NPI) is 1063746014, issued on Sep 23, 2009. An NPI identifies a provider in billing; it is not a license.

Where is Daro Mendoza Largoza, MD located?

The NPPES record lists a practice address at 50 West 34TH. St., New York, NY, 10001. Phone: (347) 526-1810. Providers update this record themselves, so call before visiting.

How can I verify Daro Mendoza Largoza, MD's license?

NPPES lists New York license number 226955, as entered by the provider. Search the New York board that licenses this profession; the NPPES record confirms identity only.

How much does Daro Mendoza Largoza, MD prescribe under Medicare Part D?

In 2024, Daro Mendoza Largoza, MD had 412 Medicare Part D claims for 36 beneficiaries; the average among research study specialist prescribers was 309. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.